Ikena Oncology, Inc.
IKNA
Revenue
658.00k
▼-527.00k▼-44.47%
3 Months ChangeAssets
157.49M
▼-15.30M▼-8.85%
3 Months ChangeLiabilities
14.63M
▼-2.81M▼-16.11%
3 Months ChangeFree Cash Flow
-19.94M
▼-119.00k▼-0.6005%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-08-08
Form 10-Q
ID: 0000950170-24-093880
2024-07-12
Form 8-K
ID: 0001193125-24-178568
2024-06-10
Form 8-K
ID: 0001193125-24-158321
2024-05-28
Form 8-K
ID: 0001193125-24-148112
2024-05-13
Form 10-Q
ID: 0000950170-24-058715
2024-02-21
Form 8-K
ID: 0001193125-24-041504
2024-01-18
Form 8-K
ID: 0001193125-24-010227
2023-11-09
Form 10-Q
ID: 0000950170-23-061535
2023-11-09
Form 8-K
ID: 0000950170-23-061519
2023-10-11
Form 8-K
ID: 0001140361-23-047880